{"id":22016,"date":"2026-06-16T23:16:00","date_gmt":"2026-06-16T21:16:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=696e465b568d0ee2aa2b7cad1221d42d"},"modified":"2026-06-16T23:16:00","modified_gmt":"2026-06-16T21:16:00","slug":"deadline-alert-adma-biologics-inc-adma-shareholders-who-lost-money-urged-to-contact-glancy-prongay-wolke-rotter-llp-about-securities-fraud-lawsuit","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=22016","title":{"rendered":"Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke &amp; Rotter LLP About Securities Fraud Lawsuit\u00a0"},"content":{"rendered":"<p>LOS ANGELES--(BUSINESS WIRE)--<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.glancylaw.com&amp;esheet=54555303&amp;newsitemid=20260616692705&amp;lan=en-US&amp;anchor=Glancy+Prongay+Wolke+%26+Rotter+LLP&amp;index=601&amp;md5=25a565c95d22e962d3a6b58189e41928\" rel=\"nofollow\" shape=\"rect\">Glancy Prongay Wolke &amp; Rotter LLP<\/a> reminds investors of the upcoming <b>August 10, 2026 <\/b>deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (\u201cADMA\u201d or the \u201cCompany\u201d) (NASDAQ: <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FADMA&amp;esheet=54555303&amp;newsitemid=20260616692705&amp;lan=en-US&amp;anchor=ADMA&amp;index=602&amp;md5=c0dce23c707439afdf557ee713236445\" rel=\"nofollow\" shape=\"rect\">ADMA<\/a>) securities between <b>August 9, 2024 and March 25, 2026<\/b>, inclusive (the \u201cClass Period\u201d).<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260616692705\/en\/2705227\/5\/Glancy_Logo_Blue.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260616692705\/en\/2705227\/22\/Glancy_Logo_Blue.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260616692705\/en\/2705227\/5\/Glancy_Logo_Blue.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260616692705\/en\/2705227\/21\/Glancy_Logo_Blue.jpg\" \/><\/a><p class=\"bwalignc\"><b>IF YOU SUFFERED A LOSS ON YOUR ADMA INVESTMENTS, CLICK <\/b><a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.glancylaw.com%2Fcases%2FADMA-Biologics-Inc%2F&amp;esheet=54555303&amp;newsitemid=20260616692705&amp;lan=en-US&amp;anchor=HERE&amp;index=603&amp;md5=7f9fd8c5bdd72151066833853296e7c0\" rel=\"nofollow\" shape=\"rect\"><b>HERE<\/b><\/a> <b>TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.<\/b><\/p><p><b>What Happened?<\/b><\/p><p>On March 24, 2026, Culper Research published a report alleging \u201cChannel Stuffing, an Undisclosed Related Party Distributor, and \u20133% Real Growth in 2025 vs. +20% Reported.\u201d Among other things, the report stated that \u201ctwo high-level employees at one of ADMA's two largest distributors,\u201d had confirmed independently that \u201c<i><b>starting in 2025, ADMA induced the distributor to stock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations. Distributors take unwanted product without having to pay for it, ADMA books the revenues, and reports growth that was never there<\/b><\/i>.\u201d<\/p><p>On this news, ADMA\u2019s stock price fell $3.96, or 29.1%, over two consecutive trading days to close at $9.63 per share on March 25, 2026, thereby injuring investors.<\/p><p><b>What Is The Lawsuit About?<\/b><\/p><p>The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, as well as failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) ADMA engaged in an undisclosed related party transaction; (2) ADMA used channel stuffing to create an appearance of revenue; (3) ADMA lacked adequate internal controls; and (4) as a result, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis at all relevant times.<\/p><p>If you purchased or otherwise acquired ADMA securities during the Class Period, you may move the Court no later than <b>August 10, 2026 <\/b>to request appointment as lead plaintiff in this putative class action lawsuit.<\/p><p><b>Contact Us To Participate or Learn More:<\/b><br\/>If you wish to\u202flearn more\u202fabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:<br\/>Charles Linehan, Esq.,<br\/>Glancy Prongay Wolke &amp; Rotter LLP,<br\/>1925 Century Park East, Suite 2100,<br\/>Los Angeles California 90067<br\/>Email: <a  href=\"mailto:shareholders@glancylaw.com\" rel=\"nofollow\" shape=\"rect\">shareholders@glancylaw.com<\/a><br\/>Telephone: 310-201-9150,<br\/>Toll-Free: 888-773-9224<br\/>Visit our website at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.glancylaw.com%2F&amp;esheet=54555303&amp;newsitemid=20260616692705&amp;lan=en-US&amp;anchor=www.glancylaw.com&amp;index=604&amp;md5=314006b27f6bf6a8ef0ee8eb8d7de8b0\" rel=\"nofollow\" shape=\"rect\">www.glancylaw.com<\/a>.<br\/>Follow us for updates on <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fglancy-prongay-murray-llp&amp;esheet=54555303&amp;newsitemid=20260616692705&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=605&amp;md5=83034f6661954bb1e64eccea654f16fc\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a>, <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FGPM_llp&amp;esheet=54555303&amp;newsitemid=20260616692705&amp;lan=en-US&amp;anchor=Twitter&amp;index=606&amp;md5=f27c7abff42c1bd301b67425909d7f0b\" rel=\"nofollow\" shape=\"rect\">Twitter<\/a>, or <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FGlancyLawFirm%2F&amp;esheet=54555303&amp;newsitemid=20260616692705&amp;lan=en-US&amp;anchor=Facebook&amp;index=607&amp;md5=e598edfe6da82d3d24f7756a04f43811\" rel=\"nofollow\" shape=\"rect\">Facebook<\/a>.<\/p><p>If you inquire by email, please include your mailing address, telephone number and number of shares purchased.<\/p><p>To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.<\/p><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p><br\/> <b>Contacts<\/b> <br\/><p class=\"bwalignl\"><b>Contact Us:<\/b><br\/>Glancy Prongay Wolke &amp; Rotter LLP,<br\/>1925 Century Park East, Suite 2100<br\/>Los Angeles, CA 90067<br\/><b>Charles Linehan<\/b><br\/>Email: <a  href=\"mailto:shareholders@glancylaw.com\" rel=\"nofollow\" shape=\"rect\">shareholders@glancylaw.com<\/a><br\/>Telephone: 310-201-9150<br\/>Toll-Free: 888-773-9224<br\/>Visit our website at: <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.glancylaw.com%2F&amp;esheet=54555303&amp;newsitemid=20260616692705&amp;lan=en-US&amp;anchor=www.glancylaw.com&amp;index=120&amp;md5=92198181621be2a339c16f62681843eb\" rel=\"nofollow\" shape=\"rect\">www.glancylaw.com<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Glancy Prongay Wolke &amp; Rotter LLP reminds investors of the upcoming August 10, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ADMA Bio&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-22016","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22016"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22016\/revisions"}],"predecessor-version":[{"id":22017,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22016\/revisions\/22017"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}